Erratum: Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome (Cancer Cell (2016) 30(14) (548–562)(S1535610816304019)(10.1016/j.ccell.2016.08.016));Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome

Cancer Cell

Volumn 30, Issue 4, 2016, Pages 548-562

  Matas Rico, Elisa ^a   van Veen, Michiel ^a   Leyton Puig, Daniela ^a   van den Berg, Jeroen ^a   Koster, Jan ^b   Kedziora, Katarzyna M ^a   Molenaar, Bas ^a   Weerts, Marjolein J A ^a   de Rink, Iris ^a   Medema, René H ^a   Giepmans, Ben N G ^a,c   Perrakis, Anastassis ^a   Jalink, Kees ^a   Versteeg, Rogier ^b   Moolenaar, Wouter H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN RECEPTOR B6; EPIDERMAL GROWTH FACTOR RECEPTOR 4; F ACTIN; FIBRONECTIN; GLYCEROPHOSPHODIESTERASE 2; GLYCEROPHOSPHODIESTERASE 4; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; GLYPICAN; GLYPICAN 6; LAMININ ALPHA4; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROGENIC DIFFERENTIATION FACTOR; PHOSPHODIESTERASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN CDC42; RAB11 PROTEIN; RAC PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SONIC HEDGEHOG PROTEIN; TIE 1 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG; WNT PROTEIN; GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE; GLYCOSYLPHOSPHATIDYLINOSITOL; GPC6 PROTEIN, HUMAN;

ARTICLE; CELL MOTILITY; CONTROLLED STUDY; CRISPR CAS SYSTEM; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEUROBLASTOMA; NEUROBLASTOMA CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; ANIMAL; CELL DIFFERENTIATION; CHICKEN; ENZYMOLOGY; HEK293 CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

ANIMALS; CELL DIFFERENTIATION; CHICKENS; GLYCOSYLPHOSPHATIDYLINOSITOLS; GLYPICANS; HEK293 CELLS; HUMANS; NEUROBLASTOMA; PHOSPHORIC DIESTER HYDROLASES; PROGNOSIS;

EID: 84991798434     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.11.008     Document Type: Erratum

References (57)

1. Allen, N.J., Bennett, M.L., Foo, L.C., Wang, G.X., Chakraborty, C., Smith, S.J., Barres, B.A., Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 486 (2012), 410–414.
2. Bewick, V., Cheek, L., Ball, J., Statistics review 12: survival analysis. Crit. Care 8 (2004), 389–394.
3. Brodeur, G.M., Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3 (2003), 203–216.
4. Brodeur, G.M., Bagatell, R., Mechanisms of neuroblastoma regression. Nat. Rev. Clin. Oncol. 11 (2014), 704–713.
5. Brodeur, G.M., Iyer, R., Croucher, J.L., Zhuang, T., Higashi, M., Kolla, V., Therapeutic targets for neuroblastomas. Expert Opin. Ther. Targets 18 (2014), 277–292.
6. Capurro, M.I., Xiang, Y.Y., Lobe, C., Filmus, J., Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res. 65 (2005), 6245–6254.
7. Capurro, M., Martin, T., Shi, W., Filmus, J., Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling. J. Cell Sci. 127 (2014), 1565–1575.
8. Chagnon, M.J., Wu, C.L., Nakazawa, T., Yamamoto, T., Noda, M., Blanchetot, C., Tremblay, M.L., Receptor tyrosine phosphatase sigma (RPTPsigma) regulates, p250GAP, a novel substrate that attenuates Rac signaling. Cell Signal. 22 (2010), 1626–1633.
9. Coles, C.H., Shen, Y., Tenney, A.P., Siebold, C., Sutton, G.C., Lu, W., Gallagher, J.T., Jones, E.Y., Flanagan, J.G., Aricescu, A.R., Proteoglycan-specific molecular switch for RPTPsigma clustering and neuronal extension. Science 332 (2011), 484–488.
10. Coles, C.H., Jones, E.Y., Aricescu, A.R., Extracellular regulation of type IIa receptor protein tyrosine phosphatases: mechanistic insights from structural analyses. Semin. Cell Dev. Biol. 37 (2015), 98–107.
11. Corda, D., Kudo, T., Zizza, P., Iurisci, C., Kawai, E., Kato, N., Yanaka, N., Mariggio, S., The developmentally regulated osteoblast phosphodiesterase GDE3 is glycerophosphoinositol-specific and modulates cell growth. J. Biol. Chem. 284 (2009), 24848–24856.
12. Corda, D., Mosca, M.G., Ohshima, N., Grauso, L., Yanaka, N., Mariggio, S., The emerging physiological roles of the glycerophosphodiesterase family. FEBS J. 281 (2014), 998–1016.
13. Filmus, J., Capurro, M., Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma. FEBS J. 280 (2013), 2471–2476.
14. Filmus, J., Capurro, M., The role of glypicans in Hedgehog signaling. Matrix Biol. 35 (2014), 248–252.
15. Filmus, J., Capurro, M., Rast, J., Glypicans. Genome Biol., 9, 2008, 224.
16. Frisca, F., Crombie, D.E., Dottori, M., Goldshmit, Y., Pebay, A., Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid. J. Lipid Res. 54 (2013), 1192–1206.
17. Gallazzini, M., Ferraris, J.D., Burg, M.B., GDPD5 is a glycerophosphocholine phosphodiesterase that osmotically regulates the osmoprotective organic osmolyte GPC. Proc. Natl. Acad. Sci. USA 105 (2008), 11026–11031.
18. Ganeshan, V.R., Schor, N.F., Pharmacologic management of high-risk neuroblastoma in children. Paediatr. Drugs 13 (2011), 245–255.
19. Govek, E.E., Newey, S.E., Van Aelst, L., The role of the Rho GTPases in neuronal development. Genes Dev. 19 (2005), 1–49.
20. Grant, B.D., Donaldson, J.G., Pathways and mechanisms of endocytic recycling. Nat. Rev. Mol. Cell Biol. 10 (2009), 597–608.
21. Guilluy, C., Garcia-Mata, R., Burridge, K., Rho protein crosstalk: another social network?. Trends Cell Biol. 21 (2011), 718–726.
22. Hall, A., Rho family GTPases. Biochem. Soc. Trans. 40 (2012), 1378–1382.
23. Hall, A., Lalli, G., Rho and Ras GTPases in axon growth, guidance, and branching. Cold Spring Harbor Perspect. Biol., 2, 2010, a001818.
24. Han, S., Ma, X., Zhao, Y., Zhao, H., Batista, A., Zhou, S., Zhou, X., Yang, Y., Wang, T., Bi, J., et al. Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer. Oncotarget, 2016, 10.18632/oncotarget.9763.
25. Hirose, M., Ishizaki, T., Watanabe, N., Uehata, M., Kranenburg, O., Moolenaar, W.H., Matsumura, F., Maekawa, M., Bito, H., Narumiya, S., Molecular disstion of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J. Cell Biol. 141 (1998), 1625–1636.
26. Holzel, M., Huang, S., Koster, J., Ora, I., Lakeman, A., Caron, H., Nijkamp, W., Xie, J., Callens, T., Asgharzadeh, S., et al. NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell 142 (2010), 218–229.
27. Jalink, K., van Corven, E.J., Hengeveld, T., Morii, N., Narumiya, S., Moolenaar, W.H., Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J. Cell Biol. 126 (1994), 801–810.
28. Jiang, M., Stanke, J., Lahti, J.M., The connections between neural crest development and neuroblastoma. Curr. Top. Dev. Biol. 94 (2011), 77–127.
29. Kedziora, K.M., Leyton-Puig, D., Argenzio, E., Boumeester, A.J., van Butselaar, B., Yin, T., Wu, Y.I., van Leeuwen, F.N., Innocenti, M., et al. Rapid remodeling of invadosomes by Gi-coupled receptors: DISSECTING THE ROLE OF Rho GTPases. J. Biol. Chem. 291 (2016), 4323–4333.
30. Kranenburg, O., Poland, M., van Horck, F.P., Drechsel, D., Hall, A., Moolenaar, W.H., Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction. Mol. Biol. Cell 10 (1999), 1851–1857.
31. Leeuwen, F.N., Kain, H.E., Kammen, R.A., Michiels, F., Kranenburg, O.W., Collard, J.G., The guanine nucleotide exchange factor Tiam1 affects neuronal morphology; opposing roles for the small GTPases Rac and Rho. J. Cell Biol. 139 (1997), 797–807.
32. Louis, C.U., Shohet, J.M., Neuroblastoma: molecular pathogenesis and therapy. Annu. Rev. Med. 66 (2015), 49–63.
33. Maris, J.M., Recent advances in neuroblastoma. N. Engl. J. Med. 362 (2010), 2202–2211.
34. Matthay, K.K., Reynolds, C.P., Seeger, R.C., Shimada, H., Adkins, E.S., Haas-Kogan, D., Gerbing, R.B., London, W.B., Villablanca, J.G., Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J. Clin. Oncol. 27 (2009), 1007–1013.
35. Moolenaar, W.H., Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem. 270 (1995), 12949–12952.
36. Molenaar, J.J., Koster, J., Zwijnenburg, D.A., van Sluis, P., Valentijn, L.J., van der Ploeg, I., Hamdi, M., van Nes, J., Westerman, B.A., van Arkel, J., et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483 (2012), 589–593.
37. Nakamura, F., FilGAP and its close relatives: a mediator of Rho-Rac antagonism that regulates cell morphology and migration. Biochem. J. 453 (2013), 17–25.
38. Novitch, B.G., Butler, S.J., Reducing the mystery of neuronal differentiation. Cell 138 (2009), 1062–1064.
39. Park, S., Lee, C., Sabharwal, P., Zhang, M., Meyers, C.L., Sockanathan, S., GDE2 promotes neurogenesis by glycosylphosphatidylinositol-anchor cleavage of RECK. Science 339 (2013), 324–328.
40. Peters, M.G., Farias, E., Colombo, L., Filmus, J., Puricelli, L., Bal de Kier Joffe, E., Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model. Breast Cancer Res. Treat. 80 (2003), 221–232.
41. Pugh, T.J., Morozova, O., Attiyeh, E.F., Asgharzadeh, S., Wei, J.S., Auclair, D., Carter, S.L., Cibulskis, K., Hanna, M., Kiezun, A., et al. The genetic landscape of high-risk neuroblastoma. Nat. Genet. 45 (2013), 279–284.
42. Raghupathy, R., Anilkumar, A.A., Polley, A., Singh, P.P., Yadav, M., Johnson, C., Suryawanshi, S., Saikam, V., Sawant, S.D., Panda, A., et al. Transbilayer lipid interactions mediate nanoclustering of lipid-anchored proteins. Cell 161 (2015), 581–594.
43. Rao, M., Sockanathan, S., Transmembrane protein GDE2 induces motor neuron differentiation in vivo. Science 309 (2005), 2212–2215.
44. Ridley, A.J., Rho GTPase signalling in cell migration. Curr. Opin. Cell Biol. 36 (2015), 103–112.
45. Sabharwal, P., Lee, C., Park, S., Rao, M., Sockanathan, S., GDE2 regulates subtype-specific motor neuron generation through inhibition of Notch signaling. Neuron 71 (2011), 1058–1070.
46. Sander, E.E., ten Klooster, J.P., van Delft, S., van der Kammen, R.A., Collard, J.G., Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol. 147 (1999), 1009–1022.
47. Spuul, P., Ciufici, P., Veillat, V., Leclercq, A., Daubon, T., Kramer, I.J., Genot, E., Importance of RhoGTPases in formation, characteristics, and functions of invadosomes. Small GTPases, 5, 2014, e28195.
48. Topanurak, S., Ferraris, J.D., Li, J., Izumi, Y., Williams, C.K., Gucek, M., Wang, G., Zhou, X., Burg, M.B., High NaCl- and urea-induced posttranslational modifications that increase glycerophosphocholine by inhibiting GDPD5 phosphodiesterase. Proc. Natl. Acad. Sci. USA 110 (2013), 7482–7487.
49. van Nes, J., Chan, A., van Groningen, T., van Sluis, P., Koster, J., Versteeg, R., A NOTCH3 transcriptional module induces cell motility in neuroblastoma. Clin. Cancer Res. 19 (2013), 3485–3494.
50. Veugelers, M., De Cat, B., Ceulemans, H., Bruystens, A.M., Coomans, C., Durr, J., Vermeesch, J., Marynen, P., David, G., Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. J. Biol. Chem. 274 (1999), 26968–26977.
51. Welz, T., Wellbourne-Wood, J., Kerkhoff, E., Orchestration of cell surface proteins by Rab11. Trends Cell Biol. 24 (2014), 407–415.
52. Yan, Y., Sabharwal, P., Rao, M., Sockanathan, S., The antioxidant enzyme Prdx1 controls neuronal differentiation by thiol-redox-dependent activation of GDE2. Cell 138 (2009), 1209–1221.
53. 2 sensor that regulates neurogenesis by controlling surface expression of GDE2. Nat. Commun., 6, 2015, 7006.
54. Yanaka, N., Mammalian glycerophosphodiester phosphodiesterases. Biosci. Biotechnol. Biochem. 71 (2007), 1811–1818.
55. Yanaka, N., Imai, Y., Kawai, E., Akatsuka, H., Wakimoto, K., Nogusa, Y., Kato, N., Chiba, H., Kotani, E., Omori, K., Sakurai, N., Novel membrane protein containing glycerophosphodiester phosphodiesterase motif is transiently expressed during osteoblast differentiation. J. Biol. Chem. 278 (2003), 43595–43602.
56. Yanaka, N., Nogusa, Y., Fujioka, Y., Yamashita, Y., Kato, N., Involvement of membrane protein GDE2 in retinoic acid-induced neurite formation in Neuro2A cells. FEBS Lett. 581 (2007), 712–718.
57. Yiu, G.K., Kaunisto, A., Chin, Y.R., Toker, A., NFAT promotes carcinoma invasive migration through glypican-6. Biochem. J. 440 (2011), 157–166.